Ekaterina Khramtsova retweeted
Please re-tweet:
We are hiring! Assistant Professor in statistical genetics. Also, hiring a postdoc. Reach out to hear more. Also, if you’ll be at #ASHG24 #ASHG2024, we could meet. careers.ashg.org/jobs/207625…
Ekaterina Khramtsova retweeted
Replying to @NancyGenetics
@NancyGenetics receiving the leadershipaward #ASHG2023 - a lighthouse for humble supportive leadership, mentorship & science that has truly fostered a generation - I owe you so much Nancy - we all do - congratulations - you deserve this so very much #iaminaweofyou ♥️🍀✨
🎉📢 In this article, I reflect on the importance of women's health and the study of sex as a biological variable (SABV). linkedin.com/pulse/road-prec…
1
2
305
🙏🏼 I express my deepest gratitude to Isabel Goldman, Sarah Geisler, and Julie Ho Sung from Cell Press for their invaluable guidance and unwavering support. Your expertise has been instrumental in this important endeavor. 🤝 #CellPressNews
1
1
128
Let's continue advancing women's health for a brighter and equitable future! 💪💊💡 #SABV #HealthEquity #PreicsionMedicine #womenshealth #ResearchCollaboration
1
94
Ekaterina Khramtsova retweeted
Today, @WHOSTP is announcing an historic slate of bold actions across government and business, civic, academic, nonprofit, community-based, and philanthropic organizations to advance the Biden-Harris Administration’s STEMM equity and excellence priorities. whitehouse.gov/ostp/news-upd…
Excited to share that our characterization of APOE Christchurch carriers in 455,306 UK Biobank participants is out on medRxiv. Feedback is welcome! medrxiv.org/content/10.1101/…
1
1
Through our evaluations of clinical diagnosis, self-reported and prescription medications, biomarker measurements, and polygenic risk scores, we found that APOECh carriers have lower levels of apolipoprotein B and have lower polygenic risk score-based AD risk.
1
1
Ekaterina Khramtsova retweeted
It is time for me to hand the baton on - but it has been a truly fantastic experience being at the helm and I strongly encourage future leaders to apply as this is a great position. Please apply and feel free to reach out to me privately with questions. 2/2
📢 Call for @FIMM_UH Director is open!
📢 Applications by 9 Jan 2023
More info:
jobs.helsinki.fi/job/Directo…
Ekaterina Khramtsova retweeted
En route to @GeneticsSociety! Lots of exciting talks & posters from the @uk_biobank Pharma Proteomics Project (UKB-PPP) partners, including GWAS, exWAS, WGS, polygenic risk scores, extreme phenotypes & MR/coloc-based drug target discovery. Check them out below! #ASHG2022
A great overview on using human genetics to improve safety assessment of therapeutics - a collaborative effort from experts across the pharmaceutical industry. Timely for #ashg22 #pharmaceutical #safety #genetics nature.com/articles/s41573-0…
1
Congratulations to @AlexanderKaurov and team on an interdisciplinary collaboration examining political trends in academia and implications for trust in science nature.com/articles/s41599-0…
Very pleased to have my first paper in Sociology published in Nature's @HSScomms together with @colognav @CharlieTyson1 and @NaomiOreskes! Changing fields after 10+ years in Astronomy is so intellectually refreshing 🍃
Ekaterina Khramtsova retweeted
Today, we are moving to make America's federally funded research freely accessible to the American public without delay. These changes will save lives & spur innovation in clean energy, cancer breakthroughs, environmental justice, and more.
Learn more ⤵️whitehouse.gov/ostp/news-upd…
Ekaterina Khramtsova retweeted
I’m currently recruiting a Bioinformatics and a Genetics Sr Scientist role within the CVMR Integrative Sciences group at Janssen. We are a team of translational bioinformaticians that intersect multi-omic data and human biology to better understand disease processes and discover
Ekaterina Khramtsova retweeted
Come join us @JanssenGlobal on an exciting postdoc program at the intersection of genomic data science and population analytics on lung cancer jobs.jnj.com/jobs/2105978102…














